Research ArticleArticle
The slowly signaling G protein-biased CB2 cannabinoid receptor agonist LY2828360 suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance and dependence
Xiaoyan Lin, Amey S. Dhopeshwarkar, Megan Huibregtse, Ken Mackie and Andrea G. Hohmann
Molecular Pharmacology November 30, 2017, mol.117.109355; DOI: https://doi.org/10.1124/mol.117.109355
Xiaoyan Lin
Indiana University
Amey S. Dhopeshwarkar
Indiana University
Megan Huibregtse
Indiana University
Ken Mackie
Indiana University
Andrea G. Hohmann
Indiana University
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
The slowly signaling G protein-biased CB2 cannabinoid receptor agonist LY2828360 suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance and dependence
Xiaoyan Lin, Amey S. Dhopeshwarkar, Megan Huibregtse, Ken Mackie and Andrea G. Hohmann
Molecular Pharmacology November 30, 2017, mol.117.109355; DOI: https://doi.org/10.1124/mol.117.109355
Research ArticleArticle
The slowly signaling G protein-biased CB2 cannabinoid receptor agonist LY2828360 suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance and dependence
Xiaoyan Lin, Amey S. Dhopeshwarkar, Megan Huibregtse, Ken Mackie and Andrea G. Hohmann
Molecular Pharmacology November 30, 2017, mol.117.109355; DOI: https://doi.org/10.1124/mol.117.109355
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement